15d033531614dc9466f80e957ac130b0feca58a3
CXCR5.md
| ... | ... | @@ -1,7 +1,13 @@ |
| 1 | +--- |
|
| 2 | +bibliography: 'morinlab.bib' |
|
| 3 | +csl: 'NLM.csl' |
|
| 4 | +link-citations: true |
|
| 5 | +--- |
|
| 1 | 6 | # CXCR5 |
| 2 | 7 | |
| 3 | 8 | ## Overview |
| 4 | 9 | CXCR5 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. No notable hot spots have been described in this gene in the context of the cancers listed below. The mutation pattern in DLBCL and FL implies the preferential accumulation of *inactivating mutations*. |
| 10 | + |
|
| 5 | 11 | ## History |
| 6 | 12 | |
| 7 | 13 | ```mermaid |
| ... | ... | @@ -16,8 +22,8 @@ timeline |
| 16 | 22 | |
| 17 | 23 | |Entity|Tier|Description | |
| 18 | 24 | |:------:|:----:|--------------------------| |
| 19 | -||2|relevance in PMBL/cHL/GZL not firmly established| |
|
| 20 | -| |1-a | aSHM target and high-confidence DLBCL gene| |
|
| 25 | +||2|relevance in PMBL/cHL/GZL not firmly established[@mottokIntegrativeGenomicAnalysis2019b]| |
|
| 26 | +| |1-a | aSHM target and high-confidence DLBCL gene[@schmitzGeneticsPathogenesisDiffuse2018a]| |
|
| 21 | 27 | |
| 22 | 28 | ## Mutation incidence in large patient cohorts (GAMBL reanalysis) |
| 23 | 29 |